Moderna’s New Flu Shot Shows Strong Results in Older Adults

Adobe Stock
Adobe Stock
Published on

Key Takeaways

  • Moderna’s mRNA flu vaccine worked better than the standard flu shot in a new trial

  • It showed 26.6% better protection in people 50 and older

  • The company said it will work with regulators on next steps

Related Stories

No stories found.
Clinical Briefing Report
clinicalbriefingreport.com